ENBIO Co., Ltd. (KOSDAQ:352940)
2,135.00
0.00 (0.00%)
At close: Feb 6, 2026
ENBIO Revenue
ENBIO had revenue of 3.94B KRW in the quarter ending September 30, 2025, a decrease of -34.84%. This brings the company's revenue in the last twelve months to 31.46B, down -10.22% year-over-year. In the year 2024, ENBIO had annual revenue of 35.65B with 4.79% growth.
Revenue (ttm)
31.46B
Revenue Growth
-10.22%
P/S Ratio
0.74
Revenue / Employee
393.21M
Employees
80
Market Cap
23.20B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 35.65B | 1.63B | 4.79% |
| Dec 31, 2023 | 34.02B | -215.53M | -0.63% |
| Dec 31, 2022 | 34.24B | 773.80M | 2.31% |
| Dec 31, 2021 | 33.47B | -1.10B | -3.17% |
| Dec 31, 2020 | 34.56B | 827.52M | 2.45% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Global SM Tech | 124.63B |
| StarFlex | 92.11B |
| Winhitech | 81.26B |
| PIMS Inc. | 66.15B |
| FINEDIGITAL | 64.28B |
| WooGene B&G | 54.77B |
| Bonne | 50.94B |
| Sejoong | 37.37B |